Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emili Montserrat

Showing results (31-40 of 184) with videos related to

Pageof 19
Sort By:
Best Practice & Research. Clinical Haematology|October 16, 2016
Present and future of personalized medicine in CLLEmili Montserrat, Tycho Bauman, Julio Delgado
Seminars in Oncology|August 27, 2003
Mechanism of action and resistance to monoclonal antibody therapyNeus Villamor, Emili Montserrat, Dolors Colomer
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2020
Comparison Between Venetoclax-based and Bruton Tyrosine Kinase Inhibitor-based Therapy as Upfront Treatment of Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Network Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
European Journal of Haematology|December 2, 2021
mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Clinical Lymphoma, Myeloma & Leukemia|April 28, 2019
Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Leukemia|May 21, 2020
CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim reportTycho Baumann, Julio Delgado, Emili Montserrat
Current Pharmaceutical Design|March 26, 2004
Cytotoxic effects of B lymphocytes mediated by reactive oxygen speciesNeus Villamor, Emili Montserrat, Dolors Colomer
The New England Journal of Medicine|June 29, 2002
Monoclonal gammopathy of undetermined significanceSilvia Montoto, Joan Bladé, Emili Montserrat
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2012
Comment on "Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors"Gerardo Ferrer, Carol Moreno, Emili Montserrat
Seminars in Oncology|April 30, 2003
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?Joan Bladé, Silvia Montoto, Laura Rosiñol, et al.
Pageof 19

Showing results (31-40 of 184) with videos related to

Sort By:
Pageof 19
Best Practice & Research. Clinical Haematology|October 16, 2016
Present and future of personalized medicine in CLLEmili Montserrat, Tycho Bauman, Julio Delgado
Seminars in Oncology|August 27, 2003
Mechanism of action and resistance to monoclonal antibody therapyNeus Villamor, Emili Montserrat, Dolors Colomer
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2020
Comparison Between Venetoclax-based and Bruton Tyrosine Kinase Inhibitor-based Therapy as Upfront Treatment of Chronic Lymphocytic Leukemia (CLL): A Systematic Review and Network Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
European Journal of Haematology|December 2, 2021
mRNA COVID-19 vaccines in patients with chronic lymphocytic leukemia: A systematic review and meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Clinical Lymphoma, Myeloma & Leukemia|April 28, 2019
Minimal Residual Disease and Survival Outcomes in Patients With Chronic Lymphocytic Leukemia: A Systematic Review and Meta-analysisStefano Molica, Diana Giannarelli, Emili Montserrat
Leukemia|May 21, 2020
CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim reportTycho Baumann, Julio Delgado, Emili Montserrat
Current Pharmaceutical Design|March 26, 2004
Cytotoxic effects of B lymphocytes mediated by reactive oxygen speciesNeus Villamor, Emili Montserrat, Dolors Colomer
The New England Journal of Medicine|June 29, 2002
Monoclonal gammopathy of undetermined significanceSilvia Montoto, Joan Bladé, Emili Montserrat
Journal of Immunology (Baltimore, Md. : 1950)|March 24, 2012
Comment on "Soluble BAFF levels inversely correlate with peripheral B cell numbers and the expression of BAFF receptors"Gerardo Ferrer, Carol Moreno, Emili Montserrat
Seminars in Oncology|April 30, 2003
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?Joan Bladé, Silvia Montoto, Laura Rosiñol, et al.
Pageof 19